G3 Pharmaceuticals

Member for

10 months 1 week
HCP ID number type
CRM
Notifications
On
Profile Complete
On
Submitted by Mykhailo.Kater… on Tue, 05/24/2022 - 10:58
Our collaboration with G3 Pharmaceuticals pursues the research and development of oral-use carbohydrate galectin-3 inhibitors, for the management of galectin-3 dependent conditions such as heart failure and chronic kidney disease.
Choose partners
Image
G3_Pharmaceuticals_Logo.jpg